Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Raluca Negricea"'
Autor:
Alexander Röth, Guangsheng He, Andres Brodsky, Chatree Chatree Chai-Adisaksopha, Teresita Dumagay, Roberta Demichelis, Martin Höglund, Richard Kelly, Je-Hwan Lee, Jun-Ichi Nishimura, Naoshi Obara, Antonio Maria Risitano, Anna Gaya, Anita Appius, Brittany Gentile, Raluca Negricea, Zilu Zhang, Simon Buatois, Bing Han
Publikováno v:
HemaSphere, Vol 7, p e72750f1 (2023)
Externí odkaz:
https://doaj.org/article/d32f9c92c0bc4d25a1163cac576a78d8
Autor:
Elizabeth L Budde, Laurie H Sehn, Matthew Matasar, Stephen J Schuster, Sarit Assouline, Pratyush Giri, John Kuruvilla, Miguel Canales, Sascha Dietrich, Keith Fay, Matthew Ku, Loretta Nastoupil, Michael C Wei, Shen Yin, Michelle Y Doral, Chi-Chung Li, Huang Huang, Raluca Negricea, Elicia Penuel, Carol O'Hear, Nancy L Bartlett
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b7208ae82289f6c41f77a1d06f254a3
https://doi.org/10.1016/s2152-2650(22)00698-x
https://doi.org/10.1016/s2152-2650(22)00698-x
Autor:
Manali Kamdar, Raluca Negricea, Iris To, Catherine Diefenbach, Kathleen A. Dorritie, Nilanjan Ghosh, Izidore S. Lossos, Julio C. Chavez, Elizabeth Budde, Maria Hristopoulos, Song Pham, C. O Hear, Amitkumar Mehta, Ling-Y Huw, Yasuhiro Oki
Publikováno v:
Hematological Oncology. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93bcb325832cb9ad3f7acc7b4a9ec8e6
https://doi.org/10.1002/hon.154_2880
https://doi.org/10.1002/hon.154_2880
Autor:
Catherine Diefenbach, Nancy L. Bartlett, Sung-Soo Yoon, Gareth P. Gregory, Michael C. Wei, Mazyar Shadman, Loretta J. Nastoupil, Elicia Penuel, Chi-Chung Li, Raluca Negricea, Sarit Assouline, Stephen J. Schuster, Shen Yin, Matthew J. Matasar, Michelle Y. Doral, L. Elizabeth Budde, Laurie H. Sehn, Chan Yoon Cheah, Won Seog Kim, Huang Huang
Publikováno v:
Blood. 136:42-44
Sarit Assouline and Won Seog Kim contributed equally. Introduction: Follicular lymphoma (FL) is considered an indolent yet incurable disease characterized by recurrent relapses: disease-free intervals shorten, and refractoriness increases with each r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::990281cc922c55d54bda7ad1fe2547cf
https://doi.org/10.1182/blood-2020-135839
https://doi.org/10.1182/blood-2020-135839
Autor:
Catherine Diefenbach, Chi-Chung Li, Loretta J. Nastoupil, Huang Huang, Stephen J. Schuster, Matthew J. Matasar, Mazyar Shadman, Chan Yoon Cheah, Won Seog Kim, Gareth P. Gregory, L. Elizabeth Budde, Sung-Soo Yoon, Elicia Penuel, Shen Yin, Raluca Negricea, Nancy L. Bartlett, Michelle Y. Doral, Michael C. Wei, Sarit Assouline, Laurie H. Sehn
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S406-S407
Context Follicular lymphoma (FL) often presents with recurrent relapses. Treatment options for patients (pts) with FL who have received ≥2 prior lines of therapy are limited, and prognosis is poor. The safety and efficacy of mosunetuzumab, a full-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60adf2df9572acd77ea78e1b40943356
https://doi.org/10.1016/s2152-2650(21)01916-9
https://doi.org/10.1016/s2152-2650(21)01916-9
Autor:
Iris To, Carol O'Hear, Ling-Yuh Huw, Catherine Diefenbach, Nilanjan Ghosh, Raluca Negricea, Yasuhiro Oki, Amitkumar Mehta, Izidore S. Lossos, Julio C. Chavez, Song Pham, Maria Hristopoulos, Kathleen A. Dorritie, Manali Kamdar, Elizabeth Budde
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S393-S394
Context Mosunetuzumab (Mosun), a full-length, humanized, IgG1 CD20xCD3 bispecific antibody, showed promising efficacy/safety for R/R B-NHL (NCT02500407; Assouline, et al. ASH 2020). Mosun combined with the anti-CD79b antibody-drug conjugate Pola show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c622edfe4dbc190ec74d3caeffb419b
https://doi.org/10.1016/s2152-2650(21)01892-9
https://doi.org/10.1016/s2152-2650(21)01892-9
Autor:
Sarit Assouline, Won Seog Kim, Laurie H. Sehn, Stephen J. Schuster, Chan Yoon Cheah, Loretta J. Nastoupil, Mazyar Shadman, Sung-Soo Yoon, Matthew J. Matasar, Catherine Diefenbach, Gareth P. Gregory, Nancy L. Bartlett, Michael C. Wei, Michelle Y. Doral, Shen Yin, Raluca Negricea, Chi-Chung Li, Elicia Penuel, Huang Huang, L. Elizabeth Budde
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S245
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0554746bda9b305d1d35ef56797020f9
https://doi.org/10.1016/s2152-2650(21)01540-8
https://doi.org/10.1016/s2152-2650(21)01540-8
Autor:
Elizabeth Budde, Nilanjan Ghosh, Julio Chavez, Izidore S. Lossos, Amitkumar Mehta, Kathleen Dorritie, Manali Kamdar, Raluca Negricea, Song Pham, Maria Hristopoulos, Ling-Yuh Huw, Carol O’Hear, Yasuhiro Oki, Iris To, Catherine Diefenbach
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S241
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3317bbf080e7e493ea56da35edc3e54
https://doi.org/10.1016/s2152-2650(21)01516-0
https://doi.org/10.1016/s2152-2650(21)01516-0
Autor:
Raluca Negricea, Kathleen A. Dorritie, Iris To, Carol O'Hear, L. Elizabeth Budde, Ling-Yuh Huw, Yasuhiro Oki, Julio C. Chavez, Manali Kamdar, Izidore S. Lossos, Nilanjan Ghosh, Song Pham, Catherine Diefenbach, Maria Hristopoulos, Amitkumar Mehta
Publikováno v:
Journal of Clinical Oncology. 39:7520-7520
7520 Background: Mosunetuzumab (M), a full-length, humanized, IgG1 bispecific antibody targeting CD20 and CD3, has shown promising efficacy and safety as monotherapy for R/R B-NHL (NCT02500407; Assouline, et al. ASH 2020). The combination of M with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce00610f381335efb4f854e2fd710ca2
https://doi.org/10.1200/jco.2021.39.15_suppl.7520
https://doi.org/10.1200/jco.2021.39.15_suppl.7520